AGC Biologics Milan Receives Special Award Mention by Confindustria for Research and Innovation
SEATTLE, November 01, 2023--AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced that the team at its Milan site has received a special mention for Research and Innovation led by Executives Under the Age of 40, one of six special mentions in the Business Prize for Innovation by Confindustria. Confindustria is the main association representing manufacturing and service companies in Italy, with a voluntary membership of more
Luca Alberici Francesco De Santis Biopharmaceutical Contract Development Manufacturing Organization Executives Under Business Prize
Source: yahoo.com